Home / Companies / IVERIC bio, Inc. / 6 Jul 2023
IVERIC bio, Inc.: meeting of 6 Jul 2023
Votes reported on Form N-PX, item by item
386 Form N-PX filers reported votes at the IVERIC bio, Inc. meeting of 6 Jul 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
2 vote records from 2 filers. 0 of the 2 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on pay tied to a merger or sale
564 vote records from 378 filers. 101 of the 360 filers that marked the item either way voted against management. 18 filers reported this item without a management mark.
4 filers reported share counts too large to be the holding described. Those figures are left out of the share split below; the counts of filers include them. How that is decided
EXTRAORDINARY TRANSACTIONSIssuer
EXTRAORDINARY TRANSACTIONS: management items
Management items in this category are shown together; filers word and number them differently.
236 vote records from 125 filers. 1 of the 125 filers that marked the item either way voted against management.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
294 vote records from 144 filers. 10 of the 144 filers that marked the item either way voted against management.
How the largest families voted
| Family | 2. Merger pay |
|---|---|
| Vanguard | Against * |
| BlackRock and iShares | For |
| Fidelity | For |
| Dimensional | Against * |
| State Street and SPDR | For |
| American Century | For |
| Franklin Templeton | Against * |
| Invesco | For |
| Equitable | Against * |
| Charles Schwab | Against * |
| Nuveen and TIAA | Against * |
| ProShares and ProFunds | For |
| John Hancock and Manulife | For |
| Morgan Stanley, Eaton Vance and Calvert | For |
| J.P. Morgan | Against * |
| Goldman Sachs | For |
| PGIM and Prudential | For |
| Jackson National funds | For |
| Northern Trust and FlexShares | Against * |
| SEI | Against * |
| T. Rowe Price | For |
| Lincoln Financial | For |
| Voya | Abstain or withhold * |
| First Trust | For |
| Russell Investments | Against * |
| Nationwide | For |
| Victory Capital | For |
| Brighthouse Funds | For |
| Guggenheim and Rydex | For |
| Columbia Threadneedle | For |
| BNY Mellon | For |
| Principal | For |
| Pacific Life funds | For |
| Federated Hermes | Abstain or withhold * |
| AllianceBernstein | Against * |
| DWS | For |
| PIMCO | For |
| Allspring | For |
| MassMutual | For |
| Virtus | For |
| Janus Henderson | For |
| Neuberger Berman | For |
| Natixis and Loomis Sayles | Against * |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the IVERIC bio, Inc. meeting?
386 Form N-PX filers reported votes at the meeting of 6 Jul 2023. On say-on-pay, 0 of 2 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by IVERIC bio, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for IVERIC bio, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing IVERIC bio, Inc. with a meeting date within three days of 6 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.